Welcome to Dtp.cancer.gov - Developmental Therapeutics Program (DTP)

dtp.cancer.gov

Description: DTP Cancer. About the Associate Director...

Google PR 5

Trustworthiness Excellent
Avg. Daily Visitors N/A

Child Safety Excellent
Avg. Daily Pageviews N/A

Privacy Excellent

Developmental Therapeutics Program (DTP)

Dtp.cancer.gov: get to the top rated DTP Cancer pages and content popular with USA-based Dtp.cancer.gov users or check the following digest to find out more. Dtp.cancer.gov is a malware-free website without age restrictions, so you can safely browse it. It seems that DTP Cancer team are just starting to conquer the social media and they have already achieved a promising result — 1 user activities so far (Twitter dominates with around 94% of all user reactions). Dtp.cancer.gov is hosted with National Institutes of Health in United States. DTP Cancer traffic is not yet estimated by Alexa.

Visit dtp.cancer.gov

Domain info

Location:	United States
Registrant:	REDACTED FOR PRIVACY
Hosted by:	National Institutes of Health
Subnetworks:	156.40.34.8

Social Media Activities

Facebook likes: -
Twitter mentions: 1
Google pluses: -
LinkedIn mentions: -
Pinterest pins: -
StumbleUpon views: -

Web Safety

This website is malware-free.
Status ok

See Google Transparency Report

Sites associated with the same registrant

Whois

Expand

Dtp.cancer.gov popular pages to visit

Developmental Therapeutics Program (DTP) About the Associate Director Rosemarie Aurigemma, Ph.D., has been a programmatic leader in drug development for over 20 years. Her tenure as the Deputy Associate Director of DTP resulted in th...

Developmental Therapeutics Program (DTP) in vivo-derived tumors and in vitro-established tumor cell lines from various species, located at the National Cancer Institute in Frederick, Maryland since the early 1960s. This DCTD Tumor Repositor...

Drug Synthesis and Chemistry Branch (DSCB) | Developmental Therapeutics Program (DTP) Selection Guidelines Structures are generally selected for screening based on their ability to add diversity to the NCI small molecule compound collection. The submission of novel heterocyclic ri...